Bio on Tap – Tickets Now on Sale!

Loading Events

Come join your bio-colleagues for an AI-focused panel discussion, networking, and draft brews (or wine) as we enjoy a long Oregon summer evening.

Artificial Intelligence (AI) and Machine Learning (ML) are spawning a cascading series of disruptive innovations that hold great promise in many fields, not the least being bioscience.

At the same time, a host of collateral considerations revolve around AI implementation. Nuts and bolts concerns include structuring patents for AI algorithms. And the datasets that algorithms reference may need attention in terms of copyright, privacy, or trade secrets.

New rules and policies regarding AI usage may require continued due diligence. While it may be permissible to use AI to assist in grant preparation, using that same tool in a peer review of that grant may not


•   Delfina Homen, J.D., Special Counsel, Miller Nash. Miller Nash is a nationally recognized law firm that, within the technology industry, assist clients in navigating the issues surrounding AI and its impact on their business.


•   Sarah Korman, Ph.D., J.D., Chief Legal Officer and Corporate Secretary, Absci. Absci is a generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients.

•   Kristy Lawton, Ph.D., Chief Science Officer, Rewire AI. Rewire AI offers integrated AI for biomedical image analysis.

•   Tuan Phamdo, Chief Executive Officer, Health Technology Innovations (HTI). HTI offers cryo-EM services supported by its AI/ML platform.

•   Julie Reed, J.D., M.B.A., Partner, Miller Nash.

Disclaimer: “This presentation is provided for informational purposes only—it does not constitute legal advice and does not create an attorney-client relationship between Miller Nash LLP and any attendee. Attendees should consult legal counsel before taking action relating to the subject matter of this presentation.”


Bio on Tap – going strong for fifteen years now – returns with its classic mix of program and networking. During our program, we’ll also welcome new Oregon Bio members, preview upcoming events, and highlight Oregon Bio news. 

July 27, 2023
Reception: 5 – 5:45 p.m. | Program: 5:45 – 6:30 p.m. | Networking: 6:30 – 8 p.m.

Online Tickets – Oregon Bio Members*
* All employees of Oregon Bio Member companies are eligible
$55: Standard  rate

Online Tickets –  Non Members:
$85:  Standard  rate

Tickets –  At the Door (subject to availability)
$105:  Standard rate

Important: The address you enter during registration must match the one on file for your credit card.  Use the Get Tickets button and select at least one ticket to continue.

Please note:  Oregon Bio takes photos and videos at our events which are used for marketing purposes. By attending this event, you agree and consent to our use of your image and voice as recorded during the event. 

Tickets will be available at the door, subject to availabilty and an additional $20 fee. Oregon Bio does not offer refunds for events, however we can transfer tickets upon request.